Initiation and development of a percutaneous left atrial appendage closure programme: A French centre's experience and literature review

• Published in: Archives of cardiovascular diseases 2023-03, Vol.116 (3), p.136-144
• Main Authors: Albert, Emeric, Puscas, Tania, Seret, Gabriel, Tence, Noémie, Amet, Denis, Varlet, Emilie, M’Barek, Dorra Raboudi, Picard, Fabien, Otmani, Akli, Sabbah, Laurent, Le Guen, Julien, Bodiguel, Eric, Domigo, Valerie, Soulat, Gilles, Spaulding, Christian, Marijon, Eloi
• Format: Article
• Language: English
• Subjects: Aged; Aged, 80 and over; Atrial Appendage; Atrial Fibrillation; Bleeding risk; Cohort Studies; Female; Hemorrhage; Humans; Left atrial appendage; Male; Observational Studies as Topic; Stroke; Stroke - etiology; Thromboembolic risk; Thromboembolism - etiology; Treatment Outcome
• ISSN: 1875-2136; 1875-2128
• DOI: 10.1016/j.acvd.2022.12.007

•Trend to fewer periprocedural complications over the years.•Significant decrease of thromboembolic and haemorrhagic events post procedure.•Almost half of haemorrhagic events occur during the first 3 months. Percutaneous left atrial appendage closure may be considered in selected patients with atrial fibrillation at significant risk of both thromboembolism and haemorrhage. To report the experience of a tertiary French centre in percutaneous left atrial appendage closure and to discuss the outcomes compared with previously published series. This was a retrospective observational cohort study of all patients referred for percutaneous left atrial appendage closure between 2014 and 2020. Patient characteristics, procedural management and outcomes were reported, and the incidence of thromboembolic and bleeding events during follow-up were compared with historical incidence rates. Overall, 207 patients had left atrial appendage closure (mean age 75.3±8.6 years; 68% men; CHA2DS2-VASc score 4.8±1.5 ; HAS-BLED score 3.3±1.1), with a 97.6% (n=202) success rate. Twenty (9.7%) patients had at least one significant periprocedural complication, including six (2.9%) tamponades and three (1.4%) thromboembolisms. Periprocedural complication rates decreased from earlier to more recent periods (from 13% before 2018 to 5.9% after; P=0.07). During a mean follow-up of 23.1±20.2 months, 11 thromboembolic events were observed (2.8% per patient-year), a 72% risk reduction compared with the estimated theoretical annual risk. Conversely, 21 (10%) patients experienced bleeding during follow-up, with almost half of the events occurring during the first 3 months. After the first 3 months, the risk of major bleeding was 4.0% per patient-year, a 31% risk reduction compared with the expected estimated risk. This real-world evaluation emphasizes the feasibility and benefit of left atrial appendage closure, but also illustrates the need for multidisciplinary expertise to initiate and develop this activity.